George ChidiThe Guardian US politics and democracy reporter was recently on holiday in Europe and was looking forward to eating her way through Paris and London, especially cheese. But when she got there, she was surprised: although the food was delicious, she realized she wasn’t eating enough.
Over the past few months, he Hannah MooreHe takes the weight-loss drug Ozempic. About 2% of the US population takes Ozempic, and the company that sells it is worth billions of dollars. It’s been a big year for semaglutide weight-loss drugs like Ozempic, but the change they’re making on American society is just beginning.
The long-term effects may surprise us all, from reduced profits for fast-food companies to breakthroughs in using drugs to treat other ailments, from kidney disease to dementia. But for Chidi, whose reporting often focuses on inequality, the price of drugs and who can afford them is also an issue. Even if drugs make countries healthier, could they also widen social inequality?
Photo: David J. Phillips/AP
